Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	38.69B -47.9%
Revenue (ttm)	1.94B +2.5%
Net Income	-388.47M
EPS	-0.30
Shares Out	1.26B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,475,265
Open	30.20
Previous Close	30.64
Day's Range	30.07 - 30.61
52-Week Range	25.58 - 62.56
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides di...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 4,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error